37 results on '"Nenna, Raffaella"'
Search Results
2. Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects
- Author
-
Tiberti, Claudio, Nenna, Raffaella, Tromba, Valeria, Filardi, Tiziana, Petrarca, Laura, Silvestri, Francesca, Fassino, Valeria, Montuori, Monica, Mancino, Enrica, Lenzi, Andrea, Midulla, Fabio, Costantino, Francesco, and Morano, Susanna
- Published
- 2023
- Full Text
- View/download PDF
3. E-cigarettes and youth: an unresolved Public Health concern
- Author
-
Virgili, Fabrizio, Nenna, Raffaella, Ben David, Shira, Mancino, Enrica, Di Mattia, Greta, Matera, Luigi, Petrarca, Laura, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
4. Italian intersociety consensus on management of long covid in children
- Author
-
Esposito, Susanna, Principi, Nicola, Azzari, Chiara, Cardinale, Fabio, Di Mauro, Giuseppe, Galli, Luisa, Gattinara, Guido Castelli, Fainardi, Valentina, Guarino, Alfredo, Lancella, Laura, Licari, Amelia, Mancino, Enrica, Marseglia, Gian Luigi, Leonardi, Salvatore, Nenna, Raffaella, Zampogna, Stefania, Zona, Stefano, Staiano, Annamaria, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
5. Comment on Walsh P, et al. Lung ultrasound allows for earlier diagnosis of bronchiolitis than auscultation: an animal experiment and human case series. J Ultrasound, 2022
- Author
-
La Regina, Domenico Paolo, Petrarca, Laura, Nenna, Raffaella, Iovine, Elio, Mancino, Enrica, and Midulla, Fabio
- Published
- 2023
- Full Text
- View/download PDF
6. Respiratory Syncytial Virus Bronchiolitis Before and After COVID-19 Pandemic: Has the Immunity Debt Been Paid Off?
- Author
-
Nenna, Raffaella, Pierangeli, Alessandra, Matera, Luigi, Petrarca, Laura, Conti, Maria Giulia, Mancino, Enrica, di Mattia, Greta, La Regina, Domenico Paolo, Virgili, Fabrizio, Papoff, Paola, Bonci, Enea, and Midulla, Fabio
- Published
- 2024
- Full Text
- View/download PDF
7. Age‐related transcript changes in type I interferon signaling in children and adolescents with long COVID.
- Author
-
Fracella, Matteo, Mancino, Enrica, Nenna, Raffaella, Virgillito, Chiara, Frasca, Federica, D'Auria, Alessandra, Sorrentino, Leonardo, Petrarca, Laura, La Regina, Domenico, Matera, Luigi, Di Mattia, Greta, Caputo, Beniamino, Antonelli, Guido, Pierangeli, Alessandra, Viscidi, Raphael P., Midulla, Fabio, and Scagnolari, Carolina
- Subjects
TYPE I interferons ,POST-acute COVID-19 syndrome ,TEENAGERS ,GENE expression ,NATURAL immunity - Abstract
SARS‐CoV‐2 typically causes mild symptoms in children, but evidence suggests that persistent immunopathological changes may lead to long COVID (LC). To explore the interplay between LC and innate immunity, we assessed the type I interferon (IFN‐I) response in children and adolescents with LC symptoms (LC; n = 28). This was compared with age‐matched SARS‐CoV‐2 recovered participants without LC symptoms (MC; n = 28) and healthy controls (HC; n = 18). We measured the mRNA expression of IFN‐I (IFN‐α/β/ε/ω), IFN‐I receptor (IFNAR1/2), and ISGs (ISG15, ISG56, MxA, IFI27, BST2, LY6E, OAS1, OAS2, OAS3, and MDA5) in PBMCs collected 3–6 months after COVID‐19. LC adolescents (12–17 years) had higher transcript levels of IFN‐β, IFN‐ε, and IFN‐ω than HC, whereas LC children (6–11 years) had lower levels than HC. In adolescents, increased levels of IFN‐α, IFN‐β, and IFN‐ω mRNAs were found in the LC group compared with MC, while lower levels were observed in LC children than MC. Adolescents with neurological symptoms had higher IFN‐α/β mRNA levels than MC. LC and MC participants showed decreased expression of ISGs and IFNAR1, but increased expression of IFNAR2, than HC. Our results show age‐related changes in the expression of transcripts involved in the IFN‐I signaling pathway in children and adolescents with LC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. SARS-CoV-2--specific mucosal immune response in vaccinated versus infected children.
- Author
-
Conti, Maria Giulia, Piano Mortari, Eva, Nenna, Raffaella, Pierangeli, Alessandra, Sorrentino, Leonardo, Frasca, Federica, Petrarca, Laura, Mancino, Enrica, Di Mattia, Greta, Matera, Luigi, Fracella, Matteo, Albano, Christian, Scagnolari, Carolina, Capponi, Martina, Cinicola, Bianca, Carsetti, Rita, and Midulla, Fabio
- Subjects
IMMUNE response ,SARS-CoV-2 ,COVID-19 vaccines ,VACCINATION of children ,VACCINATION ,SALIVA - Abstract
The anti-COVID-19 intramuscular vaccination induces a strong systemic but a weak mucosal immune response in adults. Little is known about the mucosal immune response in children infected or vaccinated against SARS-CoV-2. We found that 28% of children had detectable salivary IgA against SARS-CoV-2 even before vaccination, suggesting that, in children, SARS-CoV-2 infection may be undiagnosed. After vaccination, only receptor-binding domain (RBD)--specific IgA1 significantly increased in the saliva. Conversely, infected children had significantly higher salivary RBD-IgA2 compared to IgA1, indicating that infection more than vaccination induces a specific mucosal immune response in children. Future efforts should focus on development of vaccine technologies that also activate mucosal immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. An overview on viral interference during SARS-CoV-2 pandemic.
- Author
-
Matera, Luigi, Manti, Sara, Petrarca, Laura, Pierangeli, Alessandra, Conti, Maria Giulia, Mancino, Enrica, Leonardi, Salvatore, Midulla, Fabio, and Nenna, Raffaella
- Published
- 2024
- Full Text
- View/download PDF
10. Investigating the Relationship Between COVID‐19 and Celiac Disease. A Dual Research Approach.
- Author
-
Tiberti, Claudio, Bonamico, Margherita, Nenna, Raffaella, Petrarca, Laura, Trovato, Chiara Maria, Pietropaoli, Nicoletta, Fassino, Valeria, Midulla, Fabio, Lenzi, Andrea, Oliva, Salvatore, and Montuori, Monica
- Published
- 2023
- Full Text
- View/download PDF
11. Early genetic analysis by next‐generation sequencing improves diagnosis of primary ciliary dyskinesia.
- Author
-
Petrarca, Laura, De Luca, Alessandro, Nenna, Raffaella, Hadchouel, Alice, Mazza, Tommaso, Conti, Maria Giulia, Masuelli, Laura, Midulla, Fabio, and Guida, Valentina
- Published
- 2023
- Full Text
- View/download PDF
12. A Single Center Observational Study on Clinical Manifestations and Associated Factors of Pediatric Long COVID.
- Author
-
Mancino, Enrica, Nenna, Raffaella, Matera, Luigi, La Regina, Domenico Paolo, Petrarca, Laura, Iovine, Elio, Di Mattia, Greta, Frassanito, Antonella, Conti, Maria Giulia, Bonci, Enea, Spatuzzo, Mattia, Ialongo, Sara, Zicari, Anna Maria, Spalice, Alberto, and Midulla, Fabio
- Published
- 2023
- Full Text
- View/download PDF
13. Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth.
- Author
-
Nenna, Raffaella, Stern, Debra A., Carr, Tara F., Spangenberg, Amber, Wright, Anne L., Martinez, Fernando D., and Halonen, Marilyn
- Subjects
- *
PRENATAL exposure , *IMMUNE response , *CORD blood , *RESPIRATORY syncytial virus , *IMMUNOGLOBULINS , *BLOOD cells , *IMMUNITY - Abstract
Maternal-to-fetal transmission of respiratory syncytial virus (RSV) has been shown to occur but whether late prenatal exposure to RSV season influences offspring postnatal RSV-lower respiratory illness (LRI) risk in early life or RSV immune status at birth is unclear. In this study, the duration of third trimester RSV season exposure was determined for 1,094 newborns of the Tucson Children's Respiratory Study (TCRS) and found to show an inverse relation to risk for first RSV-LRI in the first year. Cord blood anti-RSV antibody is related to third trimester RSV season exposure but not to first year RSV-LRI risk. In a separate birth cohort (the Infant Immune Study), supernatants from cord blood mononuclear cells stimulated with the recall antigen, UV-inactivated RSV, were assayed for IFN-y and IL-4. The frequency of detectable IFN-y (but not IL-4) was increased for those with at least 2 mo of third trimester RSV season exposure, suggestive of a fetal immune response to RSV. IMPORTANCE: Our study found that duration of third trimester exposure to RSV season related inversely to subsequent risk of postnatal RSV-LRI in the first year, thus implicating this exposure as an important factor in reducing risk of postnatal RSV-LRIs, a risk reduction that appears to be independent of maternally transferred anti-RSV antibody level. The increase in frequency of detectable IFN-y and not IL-4 in response to UV-inactivated RSV in cord blood immune cells for infants with greater third trimester exposure to RSV season is suggestive of a Type-1 immune response to RSV occurring in utero. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Lung function after SARS‐CoV‐2 infection: A prospective cohort study in children.
- Author
-
Iovine, Elio, Di Mattia, Greta, Nenna, Raffaella, La Regina, Domenico Paolo, Mancino, Enrica, Petrarca, Laura, Conti, Maria Giulia, Matera, Luigi, Virgili, Fabrizio, and Midulla, Fabio
- Published
- 2023
- Full Text
- View/download PDF
15. Cytomegalovirus serology in young to mid‐adult life and decline of lung function.
- Author
-
Nenna, Raffaella, Zhai, Jing, Spangenberg, Amber, Sherrill, Duane L., Martinez, Fernando D., Halonen, Marilyn, and Guerra, Stefano
- Subjects
- *
CHRONIC obstructive pulmonary disease , *SEROLOGY , *PULMONARY function tests , *FORCED expiratory volume , *LUNGS - Abstract
Introduction: Cytomegalovirus (CMV) seropositivity has been recently linked to severity and progression of asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). To date, no longitudinal study has addressed the relation of CMV serology to levels and decline of lung function in the general adult population. Methods: We evaluated 403 participants from the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) who at enrollment were aged 28–55 years and completed lung function tests. During follow‐up, the 403 participants completed on average 7.2 lung function tests per subject for a total of 2908 observations over a mean period of 14.7 years. We tested CMV serology in serum samples from enrollment and categorized participants into low, medium, and high CMV serology based on tertiles. The relation of CMV serology at enrollment to lung function levels and decline during follow‐up was tested in multivariate random coefficients models. Results: After full adjustment, participants in the highest CMV serology tertile had faster declines of forced expiratory volume in 1 s (FEV1) and FEV1/forced vital capacity (FVC) compared with subjects in the lowest tertile (by −7.9 ml/year 95% confidence interval [−13.9 ml/year, −1.93 ml/year], and by −0.13%/year [−0.23%/year, −0.026%/year], respectively). These CMV effects were additive with those of cigarette smoking. No associations were found between CMV serology and FVC, indicating specific effects of CMV seropositivity on airflow limitation. Conclusion: High CMV serology in young to mid‐adult life may be linked to increased COPD risk through an accelerated decline of lung function. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. NRF2 Antioxidant Response and Interferon-Stimulated Genes Are Differentially Expressed in Respiratory-Syncytial-Virus- and Rhinovirus-Infected Hospitalized Children.
- Author
-
Sorrentino, Leonardo, Toscanelli, Walter, Fracella, Matteo, De Angelis, Marta, Frasca, Federica, Scagnolari, Carolina, Petrarca, Laura, Nenna, Raffaella, Midulla, Fabio, Palamara, Anna Teresa, Nencioni, Lucia, and Pierangeli, Alessandra
- Subjects
NUCLEAR factor E2 related factor ,HOSPITAL care of children ,RESPIRATORY syncytial virus infections - Abstract
Respiratory diseases caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV) are frequent causes of the hospitalization of children; nonetheless, RSV is responsible for the most severe and life-threatening illnesses. Viral infection triggers an inflammatory response, activating interferon (IFN)-mediated responses, including IFN-stimulated genes (ISG) expression with antiviral and immunomodulatory activities. In parallel, the reactive oxygen species (ROS) production activates nuclear factor erythroid 2-related factor 2 (NRF2), whose antioxidant activity can reduce inflammation by interacting with the NF-kB pathway and the IFN response. To clarify how the interplay of IFN and NRF2 may impact on clinical severity, we enrolled children hospitalized for bronchiolitis and pneumonia, and measured gene expression of type-I and III IFNs, of several ISGs, of NRF2 and antioxidant-related genes, i.e., glucose-6-phosphate dehydrogenase (G6PD), heme oxygenase 1 (HO1), and NAD(P)H dehydrogenase [Quinone] 1 (NQO1) in RSV- (RSV-A N = 33 and RSV-B N = 30) and HRV (N = 22)-positive respiratory samples. NRF2 and HO1 expression is significantly elevated in children with HRV infection compared to RSV (p = 0.012 and p = 0.007, respectively), whereas ISG15 and ISG56 expression is higher in RSV-infected children (p = 0.016 and p = 0.049, respectively). Children admitted to a pediatric intensive care unit (PICU) had reduced NRF2 expression (p = 0.002). These data suggest, for the first time, that lower activation of the NRF2 antioxidant response in RSV-infected infants may contribute to bronchiolitis severity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
- Author
-
Oliveto, Giuseppe, Scagnolari, Carolina, Frasca, Federica, Sorrentino, Leonardo, Matera, Luigi, Nenna, Raffaella, Viscido, Agnese, Scordio, Mirko, Petrarca, Laura, Maria Zicari, Anna, Gentilini, Elio, D'Ettorre, Gabriella, Ceccarelli, Giancarlo, Midulla, Fabio, Antonelli, Guido, and Pierangeli, Alessandra
- Published
- 2022
- Full Text
- View/download PDF
18. Weighing policymaking: A narrative review of school closures as COVID‐19 pandemic‐mitigation strategies.
- Author
-
Nenna, Raffaella, Zeric, Hana, Petrarca, Laura, Mancino, Enrica, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
19. Pediatric COVID-19 Follow-Up with Lung Ultrasound: A Prospective Cohort Study.
- Author
-
La Regina, Domenico Paolo, Pepino, Daniela, Nenna, Raffaella, Iovine, Elio, Mancino, Enrica, Andreoli, Gianmarco, Zicari, Anna Maria, Spalice, Alberto, and Midulla, Fabio
- Subjects
COVID-19 ,ULTRASONIC imaging ,COHORT analysis ,LONGITUDINAL method ,LUNGS - Abstract
During the COVID-19 pandemic, lung ultrasound (LUS) was widely used to assess SARS-CoV-2 infection. To date, there are patients with persistence of symptoms after acute infection. Therefore, it may be useful to have an objective tool to follow these patients. The aim of our study was to evaluate the presence of LUS artifacts after SARS-CoV-2 infection in children and to analyze the associations between time elapsed since infection and symptomatology during acute infection. We conducted an observational study, enrolling 607 children infected with SARS-CoV-2 in the previous twelve months. All patients performed a LUS and medical history of demographic and clinical data. We observed irregular pleural lines in 27.5%, B-lines in 16.9%, and subpleural consolidations in 8.6% of the cases. These artifacts were more frequently observed in the lower lobe projections. We have observed that the frequency of artifacts decreases with increasing time since infection. In symptomatic patients during COVID infection, B-lines (p = 0.02) were more frequently found. In our sample, some children, even after months of acute infection, have ultrasound artifacts and showed an improvement with the passage of time from the acute episode. Our study provides additional evidence about LUS in children with previous COVID-19 as a support to follow these patients in the months following the infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Neurological and psychological effects of long COVID in a young population: A cross-sectional study.
- Author
-
Alessia Guido, Cristiana, Lucidi, Fabio, Midulla, Fabio, Maria Zicari, Anna, Bove, Elena, Avenoso, Federica, Amedeo, Ilaria, Mancino, Enrica, Nenna, Raffaella, De Castro, Giovanna, Capponi, Martina, Laura Cinicola, Bianca, Brindisi, Giulia, Grisoni, Flavia, Murciano, Manuel, and Spalice, Alberto
- Subjects
POST-acute COVID-19 syndrome ,POST-traumatic stress ,SARS-CoV-2 - Abstract
Aim: We evaluated the long-term clinical status of pediatric patients after testing positive for COVID-19. We hypothesized that there are similar symptoms to those that have been described in adults and children and that pediatric patients with neurophysiologic symptoms still present 3-5 months after infection have psychological consequences that interfere with their adaptive functioning. Method: We recruited 322 COVID-19-positive pediatric patients, between 1.5 and 17 years old, from the outpatient clinic for COVID-19 follow-up. Neurological symptoms were analyzed at onset, after 1 month, and after 3-5 months. A psychological assessment with standardized questionnaires was also conducted to determine the impact of the disease. Results: At the onset of COVID-19, 60% of the total sample exhibited symptoms; this decreased after 1 month (20%) but stabilized 3-5 months after disease onset (22%). Prevailing long-COVID neurological symptoms were headache, fatigue, and anosmia. In the 1.5-5-year-old subgroup, internalizing problems emerged in 12% of patients. In the 6-18-year-old subgroup, anxiety and post-traumatic stress showed significant associations with neurological symptoms of long COVID. Conclusions: These data demonstrate that long COVID presents various broad-spectrum symptoms, including psychological and long-lasting cognitive issues. If not treated, these symptoms could significantly compromise the quality of life of children and adolescents. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
- Author
-
Pierangeli, Alessandra, Gentile, Massimo, Oliveto, Giuseppe, Frasca, Federica, Sorrentino, Leonardo, Matera, Luigi, Nenna, Raffaella, Viscido, Agnese, Fracella, Matteo, Petrarca, Laura, D'Ettorre, Gabriella, Ceccarelli, Giancarlo, Midulla, Fabio, Antonelli, Guido, and Scagnolari, Carolina
- Subjects
TYPE I interferons ,SARS-CoV-2 ,INTERFERONS ,YOUNG adults ,NATURAL immunity - Abstract
Children generally develop a mild disease after SARS-CoV-2 infection whereas older adults are at risk of developing severe COVID-19. Recent transcriptomic analysis showed pre-activated innate immunity in children, resulting in a more effective anti-SARS-CoV-2 response upon infection. To further characterize age-related differences, we studied type I and III interferon (IFN) response in SARS-CoV-2 infected and non-infected individuals of different ages. Specifically, levels of expression of type I (IFN-a, -b, -e and -w), type III (IFNl1, -l2 and -l3) IFNs and of the IFN-stimulated genes, ISG15 and ISG56 were quantified in nasopharyngeal cells from diagnostic swabs. Basal transcription of type I/III IFN genes was highest among children and decreased with age. Among SARS-CoV-2-infected individuals, only IFN-e and -w levels were significantly higher in children and young adults whereas ISGs were overexpressed in infected adults. The occurrence of symptoms in children and the need for hospitalization in adults were associated to higher transcription of several IFN genes. Starting from a pre-activated transcription level, the expression of type I and III IFNs was not highly up-regulated in children upon SARS-CoV-2 infection; young adults activated IFNs' transcription at intermediate levels whereas older adults were characterized by higher ISGs and lower IFN-e and -w relative expression levels. Overall, our findings contribute to recognize components of a protective IFN response as a function of age, in the context of SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. First COVID‐19 lockdown resulted in most respiratory viruses disappearing among hospitalised children, with the exception of rhinoviruses.
- Author
-
Nenna, Raffaella, Matera, Luigi, Pierangeli, Alessandra, Oliveto, Giuseppe, Viscido, Agnese, Petrarca, Laura, La Regina, Domenico Paolo, Mancino, Enrica, Di Mattia, Greta, Villani, Alberto, and Midulla, Fabio
- Subjects
- *
RHINOVIRUSES , *RESPIRATORY syncytial virus , *RESPIRATORY infections , *COVID-19 , *COVID-19 pandemic - Abstract
Aim: Emergency room admissions have decreased globally during the COVID‐19 pandemic, particularly for respiratory diseases. We evaluated hospital admissions for respiratory diseases in the first year of the Italian pandemic and compared them with the corresponding period in 2016–2017. Methods: The study was carried out at the Sapienza University in Rome, Italy, and covered 9 March to 28 February 2020–2021 and 2016–2017. We tested 85 hospitalised children who were negative for the virus that causes COVID‐19 in 2020–2021 and compared them with 476 hospitalised children from 2016–2017, as we had also tested nasal washing samples for 14 respiratory viruses during that period. Results: Hospitalisations for acute respiratory tract infections were 82.2% lower in 2020–2021 than 2016–2017. The respiratory syncytial virus (RSV) and several other viruses were detected less frequently during the pandemic. An extraordinary finding was that rhinoviruses remained seasonal. In 2020–2021, we detected a virus in 54.1% of the hospitalised children: rhinoviruses in 41, RSV in 4 and other viruses in 1. This was significantly lower than the 71.6% in 2016–2017: RSV in 130, rhinoviruses in 128 and other viruses in 83. Conclusion: Pandemic measures dramatically reduced childhood respiratory infections, particularly RSV, but were less effective at reducing rhinoviruses. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Low lymphocyte count: A clinical severity marker in infants with bronchiolitis.
- Author
-
Matera, Luigi, Nenna, Raffaella, Frassanito, Antonella, Petrarca, Laura, Mancino, Enrica, Rizzo, Valentina, Di Mattia, Greta, Paolo La Regina, Domenico, Pierangeli, Alessandra, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
24. Serum NGF and BDNF in Long-COVID-19 Adolescents: A Pilot Study.
- Author
-
Petrella, Carla, Nenna, Raffaella, Petrarca, Laura, Tarani, Francesca, Paparella, Roberto, Mancino, Enrica, Di Mattia, Greta, Conti, Maria Giulia, Matera, Luigi, Bonci, Enea, Ceci, Flavio Maria, Ferraguti, Giampiero, Gabanella, Francesca, Barbato, Christian, Di Certo, Maria Grazia, Cavalcanti, Luca, Minni, Antonio, Midulla, Fabio, Tarani, Luigi, and Fiore, Marco
- Subjects
- *
COVID-19 , *YOUNG adults , *BRAIN-derived neurotrophic factor , *CORONAVIRUS diseases , *NERVE growth factor , *TEENAGE girls - Abstract
COVID-19 (COronaVIrus Disease 19) is an infectious disease also known as an acute respiratory syndrome caused by the SARS-CoV-2. Although in children and adolescents SARS-CoV-2 infection produces mostly mild or moderate symptoms, in a certain percentage of recovered young people a condition of malaise, defined as long-COVID-19, remains. To date, the risk factors for the development of long-COVID-19 are not completely elucidated. Neurotrophins such as NGF (Nerve Growth Factor) and BDNF (Brain-Derived Neurotrophic Factor) are known to regulate not only neuronal growth, survival and plasticity, but also to influence cardiovascular, immune, and endocrine systems in physiological and/or pathological conditions; to date only a few papers have discussed their potential role in COVID-19. In the present pilot study, we aimed to identify NGF and BDNF changes in the serum of a small cohort of male and female adolescents that contracted the infection during the second wave of the pandemic (between September and October 2020), notably in the absence of available vaccines. Blood withdrawal was carried out when the recruited adolescents tested negative for the SARS-CoV-2 ("post-infected COVID-19"), 30 to 35 days after the last molecular test. According to their COVID-19 related outcomes, the recruited individuals were divided into three groups: asymptomatics, acute symptomatics and symptomatics that over time developed long-COVID-19 symptoms ("future long-COVID-19"). As a control group, we analyzed the serum of age-matched healthy controls that did not contract the infection. Inflammatory biomarkers (TNF-α, TGF-β), MCP-1, IL-1α, IL-2, IL-6, IL-10, IL-12) were also analyzed with the free oxygen radicals' presence as an oxidative stress index. We showed that NGF serum content was lower in post-infected-COVID-19 individuals when compared to healthy controls; BDNF levels were found to be higher compared to healthy individuals only in post-infected-COVID-19 symptomatic and future long-COVID-19 girls, leaving the BDNF levels unchanged in asymptomatic individuals if compared to controls. Oxidative stress and inflammatory biomarkers were unchanged in male and female adolescents, except for TGF-β that, similarly to BDNF, was higher in post-infected-COVID-19 symptomatic and future long-COVID-19 girls. We predicted that NGF and/or BDNF could be used as early biomarkers of COVID-19 morbidity in adolescents. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. The Key Role of Lung Ultrasound in the Diagnosis of a Mature Cystic Teratoma in a Child with Suspected Difficult to Treat Pneumonia: A Case Report.
- Author
-
Iovine, Elio, Petrarca, Laura, Regina, Domenico Paolo La, Matera, Luigi, Mancino, Enrica, Di Mattia, Greta, Midulla, Fabio, and Nenna, Raffaella
- Subjects
LUNG radiography ,PNEUMONIA ,C-reactive protein ,CHEST X rays ,PLEURAL effusions ,DIFFERENTIAL diagnosis ,TERATOMA ,DYSPNEA ,EARLY diagnosis ,DISEASE complications ,SYMPTOMS ,CHILDREN - Abstract
To date, the diagnosis of mediastinal teratoma and mediastinal masses relies on the use of chest X-ray and CT. Lung and thoracic ultrasound is becoming increasingly used in the diagnosis and follow-up of many lung and thoracic diseases. Here, we report the case of a mature cystic teratoma in which the performance of lung ultrasound allowed to speed up the diagnostic workup and to provide the indication for the execution of CT of the thorax allowing the diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Bronchiolitis phenotypes identified by latent class analysis may influence the occurrence of respiratory sequelae.
- Author
-
Petrarca, Laura, Nenna, Raffaella, Di Mattia, Greta, Frassanito, Antonella, Castro‐Rodriguez, Jose A., Rodriguez Martinez, Carlos E., Mancino, Enrica, Arima, Serena, Scagnolari, Carolina, Pierangeli, Alessandra, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
27. Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae.
- Author
-
Frassanito, Antonella, Nenna, Raffaella, Arima, Serena, Petrarca, Laura, Pierangeli, Alessandra, Scagnolari, Carolina, Di Mattia, Greta, Mancino, Enrica, Matera, Luigi, Porta, Daniela, Rusconi, Franca, and Midulla, Fabio
- Published
- 2022
- Full Text
- View/download PDF
28. Is There a Chance of Normal Life in Severe Laryngeal web.
- Author
-
Nenna, Raffaella, Di Mattia, Greta, Petrarca, Laura, Frassanito, Antonella, Tancredi, Giancarlo, Mollicone, Desiree, Baggi, Roberto, and Midulla, Fabio
- Subjects
- *
SYMPTOMS , *MEDICAL personnel , *RESPIRATORY obstructions , *BRONCHIOLITIS , *TEENAGERS , *YOUNG adults - Abstract
Introduction: Laryngeal web is a rare cause of pediatric stridor and respiratory distress. The clinical presentation is variable and symptoms usually correlate with the severity of the airway obstruction. Case Reports: We describe the cases of three children unexpectedly diagnosed with laryngeal web after a severe episode of bronchiolitis and after thirteen and eleven years, respectively, of persistent symptoms despite asthma medications. Conclusion: Even if it is a rare cause of stridor and respiratory distress, congenital subglottic web could be a life threatening condition and clinicians should always consider it in the differential diagnosis of persistent noisy breathing, even in adolescents and young adults. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. During the COVID‐19 pandemic where has respiratory syncytial virus gone?
- Author
-
Di Mattia, Greta, Nenna, Raffaella, Mancino, Enrica, Rizzo, Valentina, Pierangeli, Alessandra, Villani, Alberto, and Midulla, Fabio
- Published
- 2021
- Full Text
- View/download PDF
30. The use of pediatric flexible bronchoscopy in the COVID‐19 pandemic era.
- Author
-
La Regina, Domenico Paolo, Nenna, Raffaella, Schramm, Dirk, Freitag, Nadine, Goussard, Pierre, Eber, Ernst, and Midulla, Fabio
- Published
- 2021
- Full Text
- View/download PDF
31. Effects of Relaxed Lockdown on Pediatric ER Visits during SARS-CoV-2 Pandemic in Italy.
- Author
-
Matera, Luigi, Nenna, Raffaella, Ardenti Morini, Francesca, Banderali, Giuseppe, Calvani, Mauro, Calvi, Matteo, Cozzi, Giorgio, Falsaperla, Raffaele, Guidi, Roberto, Kantar, Ahmad, Lanari, Marcello, Lubrano, Riccardo, Messini, Beatrice, Niccoli, Antonio Augusto, Tipo, Vincenzo, and Midulla, Fabio
- Published
- 2021
- Full Text
- View/download PDF
32. Acute Bronchiolitis: The Less, the Better?
- Author
-
Virgili F, Nenna R, Di Mattia G, Matera L, Petrarca L, Conti MG, and Midulla F
- Subjects
- Infant, Humans, RNA, Viral therapeutic use, Systematic Reviews as Topic, Bronchodilator Agents therapeutic use, Risk Factors, Bronchiolitis diagnosis, Bronchiolitis epidemiology, Bronchiolitis therapy, Respiratory Syncytial Virus Infections diagnosis, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections therapy
- Abstract
Background: Acute bronchiolitis is a viral infection of the lower respiratory tract affecting infants aged under 12 months, variably presenting with respiratory distress, diffuse crackles and inflammatory wheezing. The main causative agent is Respiratory Syncytial Virus (RSV). The diagnosis is clinical and treatment mainly supportive. Despite the availability of more than 30 international guidelines, consistent management recommendations are lacking and considerable variability in patients' care persists among different providers., Objective: To review and describe current knowledge about epidemiology, physiopathology, clinic, diagnosis and management of acute bronchiolitis, with particular emphasis on updated evidence and future perspectives in terms of treatment and prevention., Methods and Results: We searched Cochrane for systematic reviews and PubMed for scientific articles published in the last 10 years, using a combination of the following search terms: "bronchiolitis", "respiratory syncytial virus", "epidemiology", "risk factors", "severity", "diagnosis", "clinic", "diagnostic imaging", "management", "asthma", "wheezing", "bronchodilator", "steroids", "hypertonic saline", "oxygen", "blood gas analysis", "HHHFNC", "rehydration", "enteral feeding", "parenteral hydration", "prevention", "vaccine" and "COVID-19 or SARS-CoV2". We accordingly performed a deep and extensive selection of the most updated and considerable literature on the matter, summarizing the most significant evidence concerning all aspects of acute bronchiolitis (epidemiology, clinic, diagnosis, management and prevention). Furthermore, we examined references and available guidelines from UK, USA, Canada, Italy and Spain. Results are extensively discussed below., Conclusion: Although acute bronchiolitis has been a widely known disease for decades, its therapeutic approach remained unchanged and essentially limited to respiratory and metabolic support. Despite the abundance of studies, there is no significant evidence concerning therapeutic alternatives (e.g. steroids, inhaled hypertonic solution), which are therefore not recommended. According to most recent data, "acute bronchiolitis" definition encompasses a plethora of different clinical entities related to each subject's genetic and immune predisposition. Therefore, future research should focus on the precise characterization of such subcategories in order to individualize therapeutic management and ensure the most appropriate evidence-based care., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
33. An overview on viral interference during SARS-CoV-2 pandemic.
- Author
-
Matera L, Manti S, Petrarca L, Pierangeli A, Conti MG, Mancino E, Leonardi S, Midulla F, and Nenna R
- Abstract
Respiratory viruses represent the most frequent cause of mortality, morbidity and high healthcare costs for emergency visits and hospitalization in the pediatric age. Respiratory viruses can circulate simultaneously and can potentially infect the same host, determining different types of interactions, the so-called viral interference. The role of viral interference has assumed great importance since December 2019, when the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) came on the scene. The aim of this narrative review is to present our perspective regarding research in respiratory virus interference and discuss recent advances on the topic because, following SARS-CoV-2 restrictions mitigation, we are experimenting the co-circulation of respiratory viruses along with SARS-CoV-2. This scenario is raising many concerns about possible virus-virus interactions, both positive and negative, and the clinical, diagnostic and therapeutic management of these coinfections. Moreover, we cannot rule out that also climatic conditions and social behaviours are involved. Thus, this situation can lead to different population epidemic dynamics, including changes in the age of the targeted population, disease course and severity, highlighting the need for prospective epidemiologic studies and mathematical modelling able to predict the timing and magnitude of epidemics caused by SARS-CoV-2/seasonal respiratory virus interactions in order to adjust better public health interventions., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (© 2023 Matera, Manti, Petrarca, Pierangeli, Conti, Mancino, Leonardi, Midulla and Nenna.)
- Published
- 2023
- Full Text
- View/download PDF
34. Neurological and psychological effects of long COVID in a young population: A cross-sectional study.
- Author
-
Guido CA, Lucidi F, Midulla F, Zicari AM, Bove E, Avenoso F, Amedeo I, Mancino E, Nenna R, De Castro G, Capponi M, Cinicola BL, Brindisi G, Grisoni F, Murciano M, and Spalice A
- Abstract
Aim: We evaluated the long-term clinical status of pediatric patients after testing positive for COVID-19. We hypothesized that there are similar symptoms to those that have been described in adults and children and that pediatric patients with neurophysiologic symptoms still present 3-5 months after infection have psychological consequences that interfere with their adaptive functioning., Method: We recruited 322 COVID-19-positive pediatric patients, between 1.5 and 17 years old, from the outpatient clinic for COVID-19 follow-up. Neurological symptoms were analyzed at onset, after 1 month, and after 3-5 months. A psychological assessment with standardized questionnaires was also conducted to determine the impact of the disease., Results: At the onset of COVID-19, 60% of the total sample exhibited symptoms; this decreased after 1 month (20%) but stabilized 3-5 months after disease onset (22%). Prevailing long-COVID neurological symptoms were headache, fatigue, and anosmia. In the 1.5-5-year-old subgroup, internalizing problems emerged in 12% of patients. In the 6-18-year-old subgroup, anxiety and post-traumatic stress showed significant associations with neurological symptoms of long COVID., Conclusions: These data demonstrate that long COVID presents various broad-spectrum symptoms, including psychological and long-lasting cognitive issues. If not treated, these symptoms could significantly compromise the quality of life of children and adolescents., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Guido, Lucidi, Midulla, Zicari, Bove, Avenoso, Amedeo, Mancino, Nenna, De Castro, Capponi, Cinicola, Brindisi, Grisoni, Murciano, Spalice and the Long-Covid Group of Department of Maternal Sciences.)
- Published
- 2022
- Full Text
- View/download PDF
35. An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children.
- Author
-
Nenna R, Matera L, Licari A, Manti S, Di Bella G, Pierangeli A, Palamara AT, Nosetti L, Leonardi S, Marseglia GL, and Midulla F
- Abstract
Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has been reported worldwide. We prospectively evaluated 587 children, aged <12 years, admitted for respiratory tract infections from 1 September 2021 to 15 March 2022 in four Italian pediatric hospitals to assess the burden of respiratory viruses during the COVID-19 pandemic in Italy. At admission, a Clinical Respiratory Score was assigned and nasopharyngeal or nasal washing samples were collected and tested for respiratory viruses. Total admissions increased from the second half of October 2021 to the first half of December 2021 with a peak in early November 2021. The respiratory syncytial virus (RSV) incidence curve coincided with the total hospitalizations curve, occurred earlier than in the pre-pandemic years, and showed an opposite trend with respect to the incidence rate of SARS-CoV-2. Our results demonstrated an early peak in pediatric hospitalizations for RSV. SARS-CoV-2 may exhibit a competitive pressure on other respiratory viruses, most notably RSV., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Nenna, Matera, Licari, Manti, Di Bella, Pierangeli, Palamara, Nosetti, Leonardi, Marseglia, Midulla and ICHRIS Group.)
- Published
- 2022
- Full Text
- View/download PDF
36. COVID-19 Lockdown Impacts Among Patients with Cystic Fibrosis: An Italian Regional Reference Centre Experience.
- Author
-
Boni A, Murciano M, De Luca F, Rizzo V, Cappelli C, D'Alù V, Troiani P, Nenna R, Cimino G, and Midulla F
- Subjects
- Communicable Disease Control, Cystic Fibrosis Transmembrane Conductance Regulator, Female, Humans, Male, Retrospective Studies, COVID-19 epidemiology, Cystic Fibrosis epidemiology, Cystic Fibrosis therapy
- Abstract
Background: Coronavirus pandemic has influenced our society with social distancing and management of chronic disease such as cystic fibrosis (CF). During the Italian lockdown from March to May 2020, CF patients reduced the number of outpatient visits, limited social interactions and spent more time at home. The aim of this study is to evaluate the impact of the lockdown on body mass index (BMI) and lung function tests on CF patients., Methods: We retrospectively reviewed clinical data about 111 CF patients followed in our Regional Cystic Fibrosis Reference Centre (Policlinico Umberto I, Rome) according to two periods: pre-lockdown (from October 2019-March 2020) and post-lockdown (from May 2020-October 2020). We collected data on nutritional (BMI and body weight) and lung function status; we chose the best values of the 'pre-lockdown' and 'post-lockdown' period for each patient. Patients were divided into 3 groups according to FEV1 value (Forced Expiratory Volume in the 1st second): group 1 (FEV1 <40%), group 2 (FEV1 40-70%), group 3 (FEV1 >70%). All patients received a telephone interview asking for the number of hours per week devoted to physical activity, number of pulmonary acute exacerbations and subjective evaluation of adherence to medical therapy, respiratory physiotherapy and diet, during the two periods., Results: Comparing weight, BMI and respiratory function between pre and post lockdown periods, we noticed an increase in weight during among overall patients. Male patients improved weight, BMI, FEF 25-75% (Forced Expiratory flow between 25% and 75% of vital capacity) and Tiffenau index more than female patients. The most severely compromised patients (group 1), showed a significant loss of both weight and BMI. Instead, patients with moderate respiratory function (group 2) showed a significant increase of both weight and BMI and a slightly reduced CVF (Forced Vital capacity). We found no differences among patients with good respiratory function (group 3). Comparing each clinical sub-groups, we noticed a significative improvement of weight ( p = 0.018) and BMI ( p = 0.030) among patients with moderate respiratory function compared to patients with compromised respiratory function. During lockdown, patients reported less physical activity, no variation in food amount and composition, more adherence to therapy (43%) and more consistent daily respiratory physiotherapy (47.6%)., Conclusions: Lockdown period had benefit among CF patients in terms of weight in particular in male patient. The greatest benefit on nutritional state was observed in patients with moderate reduction of respiratory function. In addition, we noted a stabilization and sometimes a slight improvement of lung function, instead of a continuous and steady decline that is normally observed in CF patients. These beneficial effects are slight but significative, bearing in mind the general worsening that CF patients experience annually., Competing Interests: The authors declare no conflict of interest., (© 2022 The Author(s). Published by IMR Press.)
- Published
- 2022
- Full Text
- View/download PDF
37. HMGB1 in Pediatric COVID-19 Infection and MIS-C: A Pilot Study.
- Author
-
Petrarca L, Manganelli V, Nenna R, Frassanito A, Ben David S, Mancino E, Garofalo T, Sorice M, Misasi R, and Midulla F
- Abstract
Objective: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, a novel syndrome known as a multisystem inflammatory syndrome in children (MIS-C) was reported in previously healthy children. A possible pro-inflammatory molecule, high-mobility group box 1 (HMGB1), may be assumed to play an important role in the pathogenesis and clinical presentation of MIS-C. We described the clinical picture of patients with MIS-C and we also aimed to test and compare HMGB1 serum levels of MIS-C patients with those of patients with previous SARS-CoV2 infection and healthy children., Study Design: We determined HMGB1 levels by Western blot in 46 patients and divided them into three groups, namely, five patients with MIS-C (median age: 8.36 years), 20 children with a history of SARS-CoV-2 infection (median age: 10.45 years), and 21 healthy children (controls) (median age: 4.84 years), without evidence of respiratory infection in the last 3 months., Results: The median level of HMGB1 in the serum of five patients with MIS-C was found to be significantly higher compared with both patients with a recent history of COVID-19 (1,151.38 vs. 545.90 densitometric units (DU), p = 0.001) and control (1,151.38 vs. 320.33 DU, p = 0.001) groups. The HMGB1 level in MIS-C patients with coronary involvement had a slightly higher value with respect to patients without coronary dilatation (1,225.36 vs. 1,030.49 DU, p = 0.248). In two of the five children with MIS-C that performed a follow-up, the HMGB1 value decreased to levels that were superimposable to the ones of the control group., Conclusion: The significantly high level of HMGB1 protein found in the serum of COVID-19 and patients with MIS-C supports its involvement in inflammatory manifestations, suggesting HMGB1 as a potential biomarker and therapeutic target in patients with severe illness., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Petrarca, Manganelli, Nenna, Frassanito, Ben David, Mancino, Garofalo, Sorice, Misasi and Midulla.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.